Combined PD-1/PD-L1 and tumor-infiltrating immune cells redefined a unique molecular subtype of high-grade serous ovarian carcinoma

BACKGROUND: High-grade serous ovarian carcinoma is highly heterogeneous, and although many studies have been conducted to identify high-grade serous ovarian carcinoma molecular subtypes that are sensitive to immunotherapy, no precise molecular subtype has been proposed to date. Immune cell infiltrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ping, Chen, Ruoxu, Zhang, Xudong, Fu, Ruiting, Tao, Lin, Jia, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759258/
https://www.ncbi.nlm.nih.gov/pubmed/35026984
http://dx.doi.org/10.1186/s12864-021-08265-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759258/
https://www.ncbi.nlm.nih.gov/pubmed/35026984
http://dx.doi.org/10.1186/s12864-021-08265-y

Ejemplares similares